Long-term management of venous thromboembolism.

نویسنده

  • Mark A Creager
چکیده

Deep vein thrombosis (DVT) is not a rare disease. General incidence of DVT is 0.2% of urban population per 1 year. It is very rare in the population of younger than 15 years-old. Older persons have higher incidence of DVT, 1.8 event will occur 1,000 person-year in 65 ~ 69 years-old, and 3.1 on 85 ~ 89 years-old people. One of important complication of DVT, especially in proximal (iliofemoral) DVT is the postthrombotic syndrome (PTS). The incidence of PTS after proximal DVT was 35~70% at 3years in old medical literature. Even in well-designed randomized clinical trials composed with adequate anticoagulation, early mobilization and long-term elastic compression, the incidence of severe grade PTS in proximal DVT is 4~8%. 1 year cumulative risk of PTS is 31% in women, and 15% in men with proximal DVT. Main purposes of proximal DVT are reduction of hemodynamic instability of DVT, and long term follow up plan to reduce incidence of PTS. Recently, there are many of attentions to facilitate acute management for proximal DVT with catheter directed thrombolysis, percutaneous transluminal angioplasty, and anticoagulation, but establishing long-term management plan, imaging and clinical follow up schedule are neglected.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era

BACKGROUND Patients who have had a venous thromboembolic event are generally advised to receive anticoagulant treatment for 3 months or longer to prevent a recurrent episode. Current guidelines recommend initial heparin and an oral vitamin K antagonist (VKA) for long-term anticoagulation. However, because of the well-described disadvantages of VKAs, including extensive food and drug interaction...

متن کامل

Management of hereditary hypercoagulable disorders.

The clinical management of individuals with hereditary hypercoaguable disorders has evolved from initial broad recommendations of lifelong anticoagulation after first event of venous thromboembolism to a more intricate individualized risk-benefit analysis as studies have begun to delineate the complexity of interactions of acquired and hereditary factors which determine the predilection to thro...

متن کامل

Venous thromboembolism: duration, IVC filters, and hypercoagulable workup.

Venous thromboembolism (VTE), which includes deep venous thrombosis (DVT) and pulmonary thromboembolism (PE), is the third most common cause of cardiovascular mortality in the U.S., after coronary heart disease and stroke. VTE is a systemic disease which may develop spontaneously (idiopathic, unprovoked) or secondary to some identifiable provocative or environmental risk factor. Classifications...

متن کامل

Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach

OPINION STATEMENT The management of patients with unprovoked venous thromboembolism is a common and challenging clinical problem. Although the initial antithrombotic management is well-established, there is uncertainty about the optimal long-term anticoagulant management, specifically whether patients should receive a short (i.e., 3- to 6-month) duration of anticoagulant therapy or indefinite a...

متن کامل

Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

BACKGROUND Standard therapy to prevent recurrent venous thromboembolism includes 3 to 12 months of treatment with full-dose warfarin with a target international normalized ratio (INR) between 2.0 and 3.0. However, for long-term management, no therapeutic agent has shown an acceptable benefit-to-risk ratio. METHODS Patients with idiopathic venous thromboembolism who had received full-dose anti...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Reviews in cardiovascular medicine

دوره 5 2  شماره 

صفحات  -

تاریخ انتشار 2004